While the impact of IFNα/β and ISGs on SARS-CoV-2 infection risk or COVID-19 disease severity remains to be fully determined, baseline IFNα/β activity may contribute to the variable disease progression reported in prior studies. Here, IFNA2 is linked to COVID-19.